Kamada (KMDA) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Kamada (KMDA) is Neutral.

The composite score behind that read is +0.10, weighing +0.20 of bullish evidence against -0.26 bearish.

Kamada last closed at $8.08, +3.86% on the session.

Against the IVW growth benchmark the position is +3.06% over the forecast window.

The read is built from 15 underlying insights — 6 bullish and 9 bearish.

Agreement across those insights is 60%.

Kamada has no graded predictions yet. We publish our accuracy across thousands of stocks in the open, misses included.

On the fundamentals StockMap ranks Kamada in the 46th percentile on valuation and the 56th percentile on return on equity, where 100 is best.

Kamada is classified under Health Care / Biotechnology, with a market capitalisation of $448.47M.

StockMap tracks Kamada as the 187th largest of the 381 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 301 Neutral, 63 Moderate Underperform and 17 Moderate Outperform.

On that composite Kamada ranks 42nd of 381 in the group, against a group median of -0.08.